HomeCompareADXSD vs PLD

ADXSD vs PLD: Dividend Comparison 2026

ADXSD yields 51.95% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.47M in total portfolio value· pulled ahead in Year 8
10 years
ADXSD
ADXSD
● Live price
51.95%
Share price
$3.85
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$435.5K
Annual income
$90,970.08
Full ADXSD calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — ADXSD vs PLD

📍 PLD pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADXSDPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADXSD + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADXSD pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADXSD
Annual income on $10K today (after 15% tax)
$4,415.58/yr
After 10yr DRIP, annual income (after tax)
$77,324.57/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,960,791.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADXSD + PLD for your $10,000?

ADXSD: 50%PLD: 50%
100% PLD50/50100% ADXSD
Portfolio after 10yr
$3.17M
Annual income
$2,420,847.63/yr
Blended yield
76.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ADXSD
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADXSD buys
0
PLD buys
0
No recent congressional trades found for ADXSD or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADXSDPLD
Forward yield51.95%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$435.5K$5.91M
Annual income after 10y$90,970.08$4,750,725.19
Total dividends collected$350.5K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ADXSD vs PLD ($10,000, DRIP)

YearADXSD PortfolioADXSD Income/yrPLD PortfolioPLD Income/yrGap
1$15,895$5,194.81$11,241$540.96+$4.7KADXSD
2$24,724$7,716.86$13,019$991.13+$11.7KADXSD
3$37,673$11,218.27$15,801$1,870.97+$21.9KADXSD
4$56,286$15,975.38$20,609$3,701.21+$35.7KADXSD
5$82,532$22,306.57$29,919$7,867.97+$52.6KADXSD
6$118,878$30,568.54$50,631$18,617.74+$68.2KADXSD
7$168,350$41,149.89$105,528$51,352.20+$62.8KADXSD
8← crossover$234,596$54,462.14$287,364$174,449.42$52.8KPLD
9$321,946$70,928.36$1,081,760$774,280.77$759.8KPLD
10$435,453$90,970.08$5,908,209$4,750,725.19$5.47MPLD

ADXSD vs PLD: Complete Analysis 2026

ADXSDStock

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.

Full ADXSD Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ADXSD vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADXSD vs SCHDADXSD vs JEPIADXSD vs OADXSD vs KOADXSD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.